全球醫用解凍系統市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計醫療解凍系統市場將從 2025 年的 2.6279 億美元成長到 2034 年的 5.67 億美元，2026 年至 2034 年的複合年成長率預計為 8.92%。

隨著醫療機構越來越依賴安全且高效的生物樣本解凍方法，全球醫用解凍系統市場正經歷顯著成長。醫用解凍系統用於在醫療程序或實驗室應用前對冷凍血液製品、血漿、幹細胞和其他生物樣本進行複溫。這些系統透過精確控制溫度，有助於維護脆弱生物樣本的完整性和安全性。

推動市場擴張的因素有很多。輸血、器官移植和先進醫療程序的需求不斷成長，使得可靠的解凍設備需求日益增加。醫院、血庫和實驗室正在採用自動化解凍系統，這些系統能夠精確控制溫度並降低污染風險。此外，生物技術和再生醫學的進步也促進了冷凍保存生物材料的使用。

受醫療科技進步的推動，醫用解凍系統市場前景依然光明。自動化、高容量解凍系統的開發可望提高醫院和研究中心的效率。生物技術研究和細胞療法投資的增加預計將進一步刺激市場需求。隨著醫療程序越來越依賴冷凍保存的生物製品，醫用解凍系統將繼續成為醫療保健基礎設施的重要組成部分。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球醫療解凍系統市場：依類型分類

• 市場分析、洞察與預測
• 手動輸入
• 自動的

第5章 全球醫療解凍系統市場：依樣本分析

• 市場分析、洞察與預測
• 血
• 胚胎
• 卵子
• 精液
• 其他

第6章 全球醫療解凍系統市場：依最終用途分類

• 市場分析、洞察與預測
• 血庫和輸血中心
• 醫院
• 組織函式庫
• 生物技術和製藥
• 其他

第7章 全球醫療解凍系統市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Helmer Scientific Inc
  • Sarstedt AG &
  • Co. KG
  • Azenta US Inc
  • GE HealthCare
  • Boekel Scientific
  • Barkey
  • Cardinal Health
  • Thermo Fisher Scientific Inc
  • Cytotherm

The Medical Thawing System Market size is expected to reach USD 567.00 Million in 2034 from USD 262.79 Million (2025) growing at a CAGR of 8.92% during 2026-2034.

The global medical thawing system market has experienced significant growth as healthcare facilities increasingly rely on safe and efficient methods for thawing biological materials. Medical thawing systems are used to warm frozen blood products, plasma, stem cells, and other biological samples before medical procedures or laboratory use. These systems ensure controlled temperature conditions that help maintain the integrity and safety of sensitive biological materials.

Several factors are driving the expansion of this market. The growing demand for blood transfusions, organ transplants, and advanced medical treatments has increased the need for reliable thawing equipment. Hospitals, blood banks, and research laboratories are adopting automated thawing systems that offer precise temperature control and reduce the risk of contamination. In addition, advancements in biotechnology and regenerative medicine are increasing the use of cryopreserved biological materials.

The future outlook for the medical thawing system market remains promising as healthcare technologies continue to advance. The development of automated and high-capacity thawing systems may improve efficiency in hospitals and research centers. Growing investments in biotechnology research and cell-based therapies are expected to create additional demand. As medical treatments increasingly rely on cryopreserved biological products, medical thawing systems will remain an essential component of healthcare infrastructure.

MARKET SEGMENTATION

By Type

• Manual
• Automated

By Sample

• Blood
• Embryo
• Ovum
• Semen
• Others

By End-use

• Blood Banks & Transfusion Centers
• Hospitals
• Tissue Banks
• Biotechnology & Pharma
• Others

COMPANIES PROFILED

• Helmer Scientific Inc, Sarstedt AG amp, Co KG, Azenta US Inc, GE HealthCare, Boekel Scientific, Barkey, Cardinal Health, Thermo Fisher Scientific Inc, Cytotherm
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MEDICAL THAWING SYSTEM MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Manual Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Automated Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MEDICAL THAWING SYSTEM MARKET: BY SAMPLE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Sample
• 5.2. Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Embryo Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Ovum Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Semen Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MEDICAL THAWING SYSTEM MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Blood Banks & Transfusion Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Tissue Banks Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Biotechnology & Pharma Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL MEDICAL THAWING SYSTEM MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Sample
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Sample
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Sample
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Sample
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Sample
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL MEDICAL THAWING SYSTEM INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Helmer Scientific Inc
  • 9.2.2 Sarstedt AG &
  • 9.2.3 Co. KG
  • 9.2.4 Azenta US Inc
  • 9.2.5 GE HealthCare
  • 9.2.6 Boekel Scientific
  • 9.2.7 Barkey
  • 9.2.8 Cardinal Health
  • 9.2.9 Thermo Fisher Scientific Inc
  • 9.2.10 Cytotherm